triprolidine
triprolidine
SMILES | Cc1ccc(/C(=C\CN2CCCC2)c2ccccn2)cc1 |
InChIKey | CBEQULMOCCWAQT-WOJGMQOQSA-N |
Chemical Properties
Hydrogen bond acceptors | 2 |
Hydrogen bond donors | 0 |
Rotatable bonds | 4 |
Molecular weight (Da) | 278.2 |
Database connections
Ligand site mutations | H1 |
Bioactivities
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
triprolidine
Drug properties
Molecular type | Small molecule |
Physiological/Surrogate | Surrogate |
Approved drug | Yes |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
5
Database connections
Ligand site mutations | H1 |
Sankey plot
Drug Information
Target | Disease | ||||||||
---|---|---|---|---|---|---|---|---|---|
Gene | Protein | Receptor family | Ligand type | Class | Name | Phase | ICD11 | ATC | Association score |